| First Author | Anderton H | Year | 2022 |
| Journal | Cell Rep | Volume | 39 |
| Issue | 10 | Pages | 110922 |
| PubMed ID | 35675765 | Mgi Jnum | J:340344 |
| Mgi Id | MGI:7311486 | Doi | 10.1016/j.celrep.2022.110922 |
| Citation | Anderton H, et al. (2022) Langerhans cells are an essential cellular intermediary in chronic dermatitis. Cell Rep 39(10):110922 |
| abstractText | SHARPIN regulates signaling from the tumor necrosis factor (TNF) superfamily and pattern-recognition receptors. An inactivating Sharpin mutation in mice causes TNF-mediated dermatitis. Blocking cell death prevents the phenotype, implicating TNFR1-induced cell death in causing the skin disease. However, the source of TNF that drives dermatitis is unknown. Immune cells are a potent source of TNF in vivo and feature prominently in the skin pathology; however, T cells, B cells, and eosinophils are dispensable for the skin phenotype. We use targeted in vivo cell ablation, immune profiling, and extensive imaging to identify immune populations driving dermatitis. We find that systemic depletion of Langerin(+) cells significantly reduces disease severity. This is enhanced in mice that lack Langerhans cells (LCs) from soon after birth. Reconstitution of LC-depleted Sharpin mutant mice with TNF-deficient LCs prevents dermatitis, implicating LCs as a potential cellular source of pathogenic TNF and highlighting a T cell-independent role in driving skin inflammation. |
